Quarterly report pursuant to Section 13 or 15(d)

Nature of Operations and Significant Accounting Policies (Tables)

v3.20.1
Nature of Operations and Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

We did not include the following potentially dilutive securities in the computation of diluted net loss per common share during the periods presented:

 

    For the three months ended March 31,  
    2020     2019  
Warrants     70,000       1,820,686  
Stock options     6,690,814       5,696,353  
Total     6,760,814       7,517,039